Shemesh Shay 4
4 · Nuvectis Pharma, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Purchase
Common Stock
2023-03-15$10.71/sh+670$7,176→ 1,361,535 total
Footnotes (2)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $9.94 to $11.00. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 48,399 shares of restricted stock and 175,000 restricted stock units.